Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Clonal evolution in cancer.

Greaves M, Maley CC.

Nature. 2012 Jan 18;481(7381):306-13. doi: 10.1038/nature10762. Review.

2.

Cancer heterogeneity--a multifaceted view.

De Sousa E Melo F, Vermeulen L, Fessler E, Medema JP.

EMBO Rep. 2013 Aug;14(8):686-95. doi: 10.1038/embor.2013.92. Epub 2013 Jul 12. Review.

3.

Clonal evolution models of tumor heterogeneity.

Shlush LI, Hershkovitz D.

Am Soc Clin Oncol Educ Book. 2015:e662-5. doi: 10.14694/EdBook_AM.2015.35.e662. Review.

4.

Adapting clinical paradigms to the challenges of cancer clonal evolution.

Murugaesu N, Chew SK, Swanton C.

Am J Pathol. 2013 Jun;182(6):1962-71. doi: 10.1016/j.ajpath.2013.02.026. Review.

5.

Advances for studying clonal evolution in cancer.

Ding L, Raphael BJ, Chen F, Wendl MC.

Cancer Lett. 2013 Nov 1;340(2):212-9. doi: 10.1016/j.canlet.2012.12.028. Epub 2013 Jan 23. Review.

6.

Intratumor diversity and clonal evolution in cancer--a skeptical standpoint.

Gisselsson D.

Adv Cancer Res. 2011;112:1-9. doi: 10.1016/B978-0-12-387688-1.00001-6. Review.

PMID:
21925299
7.

Hypoxia and regulation of cancer cell stemness.

Yun Z, Lin Q.

Adv Exp Med Biol. 2014;772:41-53. doi: 10.1007/978-1-4614-5915-6_2. Review.

8.

Differential Clonal Expansion in an Invading Cell Population: Clonal Advantage or Dumb Luck?

Newgreen DF, Zhang D, Cheeseman BL, Binder BJ, Landman KA.

Cells Tissues Organs. 2017;203(2):105-113. doi: 10.1159/000452793. Epub 2017 Feb 20. Review.

PMID:
28214862
9.

Constraints in cancer evolution.

Venkatesan S, Birkbak NJ, Swanton C.

Biochem Soc Trans. 2017 Feb 8;45(1):1-13. doi: 10.1042/BST20160229. Review.

PMID:
28202655
10.

Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.

Apostoli AJ, Ailles L.

Crit Rev Clin Lab Sci. 2016;53(1):40-51. doi: 10.3109/10408363.2015.1083944. Epub 2015 Sep 23. Review.

PMID:
26397062
11.

Cytogenetic analysis of tumor clonality.

Teixeira MR, Heim S.

Adv Cancer Res. 2011;112:127-49. doi: 10.1016/B978-0-12-387688-1.00005-3. Review.

PMID:
21925303
12.

The Complex, Clonal, and Controversial Nature of Barrett's Esophagus.

Evans JA, McDonald SA.

Adv Exp Med Biol. 2016;908:27-40. doi: 10.1007/978-3-319-41388-4_3. Review.

PMID:
27573766
13.

Natural and Chemotherapy-Induced Clonal Evolution of Tumors.

Ibragimova MK, Tsyganov MM, Litviakov NV.

Biochemistry (Mosc). 2017 Apr;82(4):413-425. doi: 10.1134/S0006297917040022. Review.

PMID:
28371598
14.

Cancer stem cells: back to Darwin?

Greaves M.

Semin Cancer Biol. 2010 Apr;20(2):65-70. doi: 10.1016/j.semcancer.2010.03.002. Epub 2010 Mar 30. Review.

PMID:
20359535
15.

Somatic clonal evolution: A selection-centric perspective.

Scott J, Marusyk A.

Biochim Biophys Acta. 2017 Apr;1867(2):139-150. doi: 10.1016/j.bbcan.2017.01.006. Epub 2017 Feb 2. Review.

PMID:
28161395
16.

[The metastatic process: history, models and recent advances].

Bidard FC, Poupon MF.

Med Sci (Paris). 2012 Jan;28(1):89-95. doi: 10.1051/medsci/2012281022. Epub 2012 Jan 27. Review. French.

17.

Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.

Prick J, de Haan G, Green AR, Kent DG.

Exp Hematol. 2014 Oct;42(10):841-51. doi: 10.1016/j.exphem.2014.07.268. Epub 2014 Sep 6. Review.

PMID:
25201757
18.

Intra-tumour heterogeneity - going beyond genetics.

Caiado F, Silva-Santos B, Norell H.

FEBS J. 2016 Jun;283(12):2245-58. doi: 10.1111/febs.13705. Epub 2016 Apr 1. Review.

19.

Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.

Gillies RJ, Verduzco D, Gatenby RA.

Nat Rev Cancer. 2012 Jun 14;12(7):487-93. doi: 10.1038/nrc3298. Review.

20.

Evolutionary determinants of cancer.

Greaves M.

Cancer Discov. 2015 Aug;5(8):806-20. doi: 10.1158/2159-8290.CD-15-0439. Epub 2015 Jul 20. Review.

Supplemental Content

Support Center